Zeo ScientifiX, Inc. Q1 2026 Financial Report: Key Highlights and Investor Takeaways

Summary of the Report

Zeo ScientifiX, Inc. (OTC: ZEOX) has released its quarterly report for the period ending January 31, 2026. This report contains several critical financial updates and disclosures that may be price-sensitive for shareholders and could impact the company’s share value. Investors are urged to review the following highlights and risks.

Key Financial Highlights

• Net Loss: The company reported a net loss of \$852,000 for the three months ended January 31, 2026, compared to a loss of \$1,243,000 for the same quarter in the prior year, indicating a reduction in net loss year-over-year.
• Total Stockholders’ Deficit: As of January 31, 2026, total stockholders’ deficit increased to (\$1,805,000) from (\$1,423,000) as of October 31, 2025, reflecting ongoing challenges in capital structure and profitability.
• Common Stock Issuance: During the quarter, the company issued 325,000 shares of common stock, raising approximately \$1,300,000 in new capital. The number of common shares outstanding increased to 7,614,941 as of January 31, 2026. As of March 16, 2026, there were 7,777,441 shares outstanding.
• Negative Cash Flow from Operations: Zeo ScientifiX continued to use cash in its operations, highlighting an ongoing dependence on external financing and capital raises to fund operations and research and development.
• Equity in Non-Marketable Securities: The company’s investment in non-marketable securities was fully reserved, with a carrying value of \$145,000 offset by an equal reserve, indicating no net impact on the balance sheet from these investments.
• Convertible Debt: The company has outstanding convertible promissory notes with a minimum conversion price of \$6.00 per share, which could dilute existing shareholders if converted.
• Shares Subject to Possible Redemption: An obligation to repurchase shares amounting to \$19,000 remains outstanding, which could affect liquidity.

Going Concern Warning

Substantial Doubt About Going Concern: The company’s management and its independent auditor have both issued warnings regarding Zeo ScientifiX’s ability to continue as a going concern. As of January 31, 2026, there remains substantial doubt that the company can continue operating for the next 12 months without raising additional capital or achieving a stabilized source of revenue. If the company cannot secure additional funding or stabilize revenue, it may be forced to consider asset sales, closure of operations, or seek bankruptcy protection.

Other Material Disclosures & Risks

• Ongoing Losses and Capital Dependence: The company continues to incur losses and is dependent on raising further capital to fund operations and research and development. It currently does not have assets to pledge for borrowing and may find future funding to be costly and dilutive, or unavailable.
• Product Revenue and Market Risks: Zeo ScientifiX’s ability to produce and sell its products is subject to changing technology and regulations. The company has not yet achieved stable revenue sources, which further compounds the risks to its ongoing viability.
• Potential Dilution: With ongoing issuances of common stock and the presence of convertible notes, shareholders face the risk of further dilution.
• No Preferred Stock Outstanding: The company’s Series C preferred stock balance remains at zero, with no preferred stock outstanding.
• Stock Compensation: The company issued 542,500 shares as compensation during the quarter, valued at \$192,000, reflecting its use of equity for compensation in the absence of sufficient cash.
• Negative Operating Cash Flow: The company’s cash flow from operations remains negative, and cash provided by investing activities was negative \$14,000 in the quarter, further straining liquidity.

Shareholder Classification and Reporting Compliance

• Filing and Reporting: Zeo ScientifiX is a non-accelerated filer and a smaller reporting company. It is compliant with filing requirements and has submitted all Interactive Data Files as required by the SEC.
• Not a Shell Company: The company has certified that it is not a shell company.
• No Emerging Growth Election: The company is not classified as an emerging growth company and has not elected the extended transition period for complying with new or revised financial accounting standards.

Potential Price-Sensitive Events

• Going Concern Risk: The explicit warning that the company may not be sustainable without new funding or a turnaround in business is highly price sensitive and could severely impact share price.
• Share Dilution and Capital Raises: The continued issuance of new shares and the likelihood of further capital raises may dilute existing shareholders and weigh on the share price.
• Convertible Debt Overhang: The outstanding convertible notes with a conversion price at a significant premium to current trading levels could result in future dilution if the stock price appreciates.
• Ongoing Losses and Liquidity Concerns: The persistent net losses and negative cash flow heighten the risk profile for investors.

Conclusion

Zeo ScientifiX, Inc. remains in a precarious financial position, with risks around going concern, ongoing losses, the need for additional capital, potential dilution, and an unstable revenue base. These factors are of critical importance to shareholders and could be highly price-sensitive. Investors should monitor developments closely and consider these risks in any investment decision.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should read the full SEC filings and consult their financial advisor before making any investment decisions. The author and publisher assume no liability for investment decisions made based on this article.

View Zeo ScientifiX, Inc. Historical chart here